Microbot Medical Inc - Asset Resilience Ratio

Latest as of March 2026: 88.19%

Microbot Medical Inc (MBOT) has an Asset Resilience Ratio of 88.19% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$68.84 Million
Cash + Short-term Investments

Total Assets

$78.07 Million
All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (1998–2025)

This chart shows how Microbot Medical Inc's Asset Resilience Ratio has changed over time. Check Microbot Medical Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Microbot Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see MBOT market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $68.84 Million 88.19%
Total Liquid Assets $68.84 Million 88.19%

Asset Resilience Insights

  • Very High Liquidity: Microbot Medical Inc maintains exceptional liquid asset reserves at 88.19% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Microbot Medical Inc Industry Peers by Asset Resilience Ratio

Compare Microbot Medical Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Autek China Inc
SHE:300595
Medical Instruments & Supplies 21.20%
Pegavision
TW:6491
Medical Instruments & Supplies 17.14%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
Jiangsu Nanfang Medical
SHG:603880
Medical Instruments & Supplies 2.46%
Interojo Inc
KQ:119610
Medical Instruments & Supplies 6.55%
I.Ceram SA
PA:ALICR
Medical Instruments & Supplies -1.61%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%

Annual Asset Resilience Ratio for Microbot Medical Inc (1998–2025)

The table below shows the annual Asset Resilience Ratio data for Microbot Medical Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 91.58% $74.68 Million $81.54 Million +52.52pp
2024-12-31 39.06% $2.36 Million $6.03 Million -7.97pp
2023-12-31 47.04% $3.92 Million $8.33 Million -13.36pp
2022-12-31 60.40% $5.76 Million $9.54 Million +48.47pp
2021-12-31 11.92% $2.00 Million $16.77 Million -7.10pp
2020-12-31 19.02% $5.00 Million $26.28 Million +12.23pp
2019-12-31 6.79% $2.52 Million $37.13 Million +6.55pp
2017-12-31 0.25% $27.00K $11.02 Million -14.75pp
2016-12-31 14.99% $505.00K $3.37 Million +70.01pp
2015-12-31 -55.02% $-11.67 Million $21.22 Million -55.02pp
2014-12-31 0.00% $-397.00 $32.43 Million --
2013-12-31 0.00% $0.00 $41.56 Million --
2012-12-31 46.07% $13.90 Million $30.17 Million +33.06pp
2011-12-31 13.02% $3.28 Million $25.21 Million +12.39pp
2010-12-31 0.62% $190.80K $30.60 Million +0.24pp
2009-12-31 0.38% $197.00K $51.19 Million -9.76pp
2008-12-31 10.14% $4.18 Million $41.23 Million -45.15pp
2007-12-31 55.29% $26.70 Million $48.28 Million +49.11pp
2006-12-31 6.18% $4.13 Million $66.86 Million -48.71pp
2000-12-31 54.90% $16.36 Million $29.79 Million +26.02pp
1998-12-31 28.88% $9.50 Million $32.90 Million --
pp = percentage points

About Microbot Medical Inc

NASDAQ:MBOT USA Medical Instruments & Supplies
Market Cap
$115.52 Million
Market Cap Rank
#18575 Global
#4282 in USA
Share Price
$1.72
Change (1 day)
-1.15%
52-Week Range
$1.62 - $4.50
All Time High
$891.00
About

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, periph… Read more